Abstract

Discrepancies in blood pressure (BP) estimates lead to incomparable BP assessment. To determine intraindividual discrepancies in BP estimates and classifications based on different BP estimation protocols. This cross-sectional study was a secondary analysis of data from the May Measurement Month Taiwan in 2017 and 2018, which were cross-sectional survey campaigns at pharmacies nationwide to raise awareness of high BP. Participants were volunteers aged 20 years or older. Analysis was conducted from February 2 to August 7, 2020. Pharmacist-measured sitting BP using oscillometric sphygmomanometers. A total of 7 BP estimation protocols were assessed according to the latest American College of Cardiology (ACC), Chinese Hypertension League (CHL), European Society of Cardiology (ESC), International Society of Hypertension, Japanese Society of Hypertension, and National Institute of Health and Care Excellence (NICE) hypertension guidelines, and the proposed Averaging the Lowest Two systolic readings protocol. According to BP classification schemes of ESC and ACC guidelines, intraindividual discrepancies were identified if classification inconsistencies among 7 BP estimates were present. Of 81 041 participants, 62 647 adults with 3 BP readings were included. The median (interquartile range) age was 59.0 (46.0-69.0) years, and 31 922 (51.5%) were women. The intraindividual maximum mean (SD) differences in systolic/diastolic BP estimates among the seven protocols were 4.8 (4.3)/3.3 (3.1) mm Hg. The highest prevalence of BP of 140/90 mm Hg or higher was by CHL (16 405 participants [26.2%]) and the lowest was by Averaging the Lowest Two (13 996 participants [22.3%]; P < .001); while the highest prevalence of 130/80 mm Hg or higher was by NICE (37 232 participants [59.4%]) and the lowest prevalence was by Averaging the Lowest Two (32 788 participants [52.4%]; P < .001). Compared with the other 6 estimates, Averaging the Lowest Two reclassified 7.3% to 15.8% of participants designated as 140/90 mm Hg or higher to less than 140/90 mm Hg, and 4.9% to 14.1% of those as 130/80 mm Hg or higher to less than 130/80 mm Hg. Intraindividual discrepancies in classifications occurred in 19 815 participants (31.6%) with the ESC classification and 16 401 participants (26.2%) with the ACC BP classification. Classification agreements were the lowest between NICE (κ coefficient, 0.667 [95% CI, 0.662-0.671]) and ESC protocols (κ coefficient, 0.705 [95% CI, 0.701-0.709]). This cross-sectional study of adults in Taiwan found that different BP estimation protocols led to considerable intraindividual discrepancies in BP estimates and classifications. These findings suggest that the Averaging the Lowest Two protocol is less likely to overestimate BP and could serve as a prudent recommendation for BP estimation.

Highlights

  • While increasing awareness of and screening for high blood pressure (BP) are important for improving BP control,[1] obtaining a reliable BP estimate is the cornerstone for the BP-guided diagnosis and management of hypertension.[2]

  • The highest prevalence of BP of 140/90 mm Hg or higher was by Chinese Hypertension League (CHL) (16 405 participants [26.2%]) and the lowest was by Averaging the Lowest Two (13 996 participants [22.3%]; P < .001); while the highest prevalence of 130/80 mm Hg or higher was by National Institute of Health and Care Excellence (NICE) (37 232 participants [59.4%]) and the lowest prevalence was by Averaging the Lowest Two (32 788 participants [52.4%]; P < .001)

  • This cross-sectional study of adults in Taiwan found that different BP estimation protocols led to considerable intraindividual discrepancies in BP estimates and

Read more

Summary

Introduction

While increasing awareness of and screening for high blood pressure (BP) are important for improving BP control,[1] obtaining a reliable BP estimate is the cornerstone for the BP-guided diagnosis and management of hypertension.[2] Given that increasing visit-to-visit systolic BP variability by 5 mm Hg contributed to a 10% increase in the risk of death[3] and lowering the definition of hypertension from 140/90 mm Hg or higher to 130/80 mm Hg or higher was associated with a 14% increase in prevalence,[4] it is conceivable that variations of repeated BP measurements and inconsistent BP estimation protocols could lead to inaccurate assessment of cardiovascular risks and inappropriate management of hypertension. BP varies with time and is subject to the effects of long-acting pathophysiological alterations superimposed by short-acting stress stimuli.[5] the high reproducibility and low variations of BP measurements are fundamental to the reliability of BP estimates. To reduce the outcomes associated with of short-acting stress on the reproducibility of BP measurements, current hypertension guidelines unanimously provide standardized recommendations regarding how to accurately measure BP.[4,7,8]

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call